
CSL and Arcturus Announce Breakthrough COVID-19 Vaccine Study Results
KING OF PRUSSIA, PA — Biotechnology giants CSL and Arcturus Therapeutics have announced promising results from a comprehensive study of their novel COVID-19 vaccine, ARCT-154. The findings, published in Nature …
CSL and Arcturus Announce Breakthrough COVID-19 Vaccine Study Results Read More